88 ANB032, a novel BTLA agonist monoclonal antibody, inhibits T cell proliferation, reduces inflammatory cytokines, and down modulates BTLA expression on circulating T and B cells

Autor: Luu, K., Randazzo, B., Hare, E., Hsu, M., Haines, C., Dahl, M., Sibley, C., Lizzul, P.
Zdroj: In Journal of Investigative Dermatology November 2023 143(11) Supplement:S347-S347
Databáze: ScienceDirect